Luk-Chiu Li

Title: The Innovations of Luk-Chiu Li

Introduction

Luk-Chiu Li is a notable inventor based in Lake Forest, IL (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of formulations for buprenorphine. His work has the potential to improve the delivery and effectiveness of this important medication.

Latest Patents

Luk-Chiu Li holds 1 patent for his invention titled "Sustained release parenteral formulations of buprenorphine." This patent describes an oil-in-water buprenorphine formulation that includes buprenorphine and a surfactant to emulsify the drug in oil. The release of the drug is controlled by varying the oil concentration and/or pH. Additionally, he has developed a buprenorphine aqueous suspension formulation that includes a free base buprenorphine and a suspension stabilizer, as well as a buprenorphine oil formulation that contains a buprenorphine salt suspended in a pharmaceutically acceptable oil. His methods provide sustained release of buprenorphine over a period of time, which can enhance patient outcomes.

Career Highlights

Luk-Chiu Li is associated with Abbott Laboratories Corporation, a leading company in the healthcare sector. His work at Abbott has allowed him to focus on innovative drug delivery systems that can significantly impact patient care.

Collaborations

Luk-Chiu Li has collaborated with talented coworkers such as Carmela H Luangdilok and Douglas R Flanagan. These collaborations have likely contributed to the success of his research and the development of his patented formulations.

Conclusion

Luk-Chiu Li's contributions to the field of pharmaceuticals, particularly through his patent on buprenorphine formulations, demonstrate his commitment to innovation in drug delivery. His work has the potential to improve therapeutic outcomes for patients requiring this medication.